Clinical trials
Fatigue trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 6 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 6 |
| 2014 | 7 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 3 |
| 2024 | 5 |
| 2025 | 4 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 57 |
| Recruiting | 9 |
| Unknown status | 7 |
| Terminated | 4 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
| Suspended | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Health Network, Toronto | 8 |
| The Hospital for Sick Children | 5 |
| University of Alberta | 5 |
| University of Calgary | 4 |
| Ottawa Hospital Research Institute | 3 |
| Pfizer | 3 |
| University of British Columbia | 3 |
| University of Ottawa | 3 |
| Brock University | 2 |
| CHU de Quebec-Universite Laval | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fatigue | 81 |
| Neoplasms | 13 |
| Multiple Sclerosis | 8 |
| Breast Neoplasms | 7 |
| Anxiety Disorders | 5 |
| Pain | 5 |
| Prostatic Neoplasms | 5 |
| Anorexia | 4 |
| Cachexia | 4 |
| Cognitive Dysfunction | 4 |
Trials
Showing 76 to 81 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.